ANTIBIOTIC RESISTANCE;
ARTICLE;
CONSENSUS DEVELOPMENT;
COST EFFECTIVENESS ANALYSIS;
DISEASE CARRIER;
EVIDENCE BASED MEDICINE;
HEALTH CARE POLICY;
HEALTH CARE SYSTEM;
HEALTH PROGRAM;
HUMAN;
INFECTION CONTROL;
MORBIDITY;
NONHUMAN;
PARASITE CLEARANCE;
PLASMODIUM VIVAX MALARIA;
PRACTICE GUIDELINE;
PREGNANCY;
PREVENTIVE MEDICINE;
PUBLICATION;
TREATMENT PLANNING;
DRUG RESISTANCE;
GLOBAL HEALTH;
HEALTH SURVEY;
MALARIA;
WORLD HEALTH ORGANIZATION;
ANTIMALARIALS;
ARTEMISININS;
DRUG RESISTANCE;
GLOBAL HEALTH;
HEALTH POLICY;
HUMANS;
MALARIA;
PUBLIC HEALTH SURVEILLANCE;
WORLD HEALTH ORGANIZATION;
Inaugural meeting of the malaria policy advisory committee to the WHO: Conclusions and recommendations
WHO Malaria Policy Advisory Committee and Secretariat
WHO Malaria Policy Advisory Committee and Secretariat. Inaugural meeting of the malaria policy advisory committee to the WHO: conclusions and recommendations. Malar J. 2012;11:137.
Malaria Policy Advisory Committee to the WHO: Conclusions and recommendations of September 2012 meeting
WHO Malaria Policy Advisory Committee and Secretariat
WHO Malaria Policy Advisory Committee and Secretariat. Malaria Policy Advisory Committee to the WHO: conclusions and recommendations of September 2012 meeting. Malar J. 2012;11:424.
Malaria Policy Advisory Committee to the WHO: Conclusions and recommendations of March 2013 meeting
WHO Malaria Policy Advisory Committee and Secretariat
WHO Malaria Policy Advisory Committee and Secretariat. Malaria Policy Advisory Committee to the WHO: conclusions and recommendations of March 2013 meeting. Malar J. 2013;12:213.
Malaria Policy Advisory Committee to the WHO: Conclusions and recommendations of September 2013 meeting
WHO Malaria Policy Advisory Committee and Secretariat
WHO Malaria Policy Advisory Committee and Secretariat. Malaria Policy Advisory Committee to the WHO: conclusions and recommendations of September 2013 meeting. Malar J. 2013;12:456.
Malaria Policy Advisory Committee to the WHO: Conclusions and recommendations of March 2014 meeting
WHO Malaria Policy Advisory Committee and Secretariat
WHO Malaria Policy Advisory Committee and Secretariat. Malaria Policy Advisory Committee to the WHO: conclusions and recommendations of March 2014 meeting. Malar J. 2014;13:253.
Malaria Policy Advisory Committee to the WHO: Conclusions and recommendations of sixth biannual meeting (September 2014)
WHO Malaria Policy Advisory Committee and Secretariat
WHO Malaria Policy Advisory Committee and Secretariat. Malaria Policy Advisory Committee to the WHO: conclusions and recommendations of sixth biannual meeting (September 2014). Malar J. 2014;14:107.
Malaria Policy Advisory Committee to the WHO: Conclusions and recommendations of seventh biannual meeting (March 2015)
WHO Malaria Policy Advisory Committee and Secretariat 4524000
WHO Malaria Policy Advisory Committee and Secretariat. Malaria Policy Advisory Committee to the WHO: conclusions and recommendations of seventh biannual meeting (March 2015). Malar J. 2015;14:295.
Report from the Global Malaria Programme, presented by Pedro Alonso on behalf of the global malaria team. World Health Organization. 2015. http://www.who.int/entity/malaria/mpac/mpac-sept2015-director-update.pdf. Accessed 5 Feb 2016.
Global Technical Strategy for Malaria 2016-2030. World Health Organization Accessed 5 Feb 2016
Global Technical Strategy for Malaria 2016-2030. World Health Organization. 2015. http://www.who.int/malaria/publications/atoz/9789241564991/en/. Accessed 5 Feb 2016.
(2015)
13
84959334317
World Health Organization Accessed 5 Feb 2016
Resolution WHA68.2: global technical strategy and targets for malaria 2016-2030. World Health Organization. 2015. http://apps.who.int/gb/ebwha/pdf-files/WHA68/A68-R2-en.pdf. Accessed 5 Feb 2016.
Action and Investment to defeat Malaria 2016-2030 - For a malaria-free world
Accessed 5 Feb 2016
Action and Investment to defeat Malaria 2016-2030 - for a malaria-free world. Roll Back Malaria Partnership. 2015. http://www.rollbackmalaria.org/about/about-rbm/aim-2016-2030. Accessed 5 Feb 2016.
3rd ed. World Health Organization Accessed 5 Feb 2016
Guidelines for the treatment of malaria. 3rd ed. World Health Organization. 2015. http://www.who.int/malaria/publications/atoz/9789241549127/en/. Accessed 5 Feb 2016.
2nd ed. World Health Organization Accessed 5 Feb 2016
Indoor residual spraying: an operational manual for IRS for malaria transmission, control and elimination. 2nd ed. World Health Organization. 2015. http://www.who.int/malaria/publications/atoz/9789241508940/en/. Accessed 5 Feb 2016.
Eliminating malaria: case study 10. Successful elimination and prevention of re-establishment of malaria in Tunisia. World Health Organization. 2015. http://www.who.int/malaria/publications/atoz/9789241509138/en/. Accessed 5 Feb 2016.
Control and elimination of Plasmodium vivax malaria - a technical brief. World Health Organization. 2015. http://www.who.int/malaria/publications/atoz/9789241509244/en/. Accessed 5 Feb 2016.
Evidence Review Group on MDA, MSAT and FSAT, presented on 16 Sept 2015. World Health Organization Accessed 5 Feb 2016
Evidence Review Group on MDA, MSAT and FSAT, presented on 16 Sept 2015. World Health Organization. 2015. http://www.who.int/malaria/mpac/mpac-sept2015-erg-mda-presentation.pdf. Accessed 5 Feb 2016.
(2015)
20
84959410109
Mass drug administration, mass screening and treatment and focal screening and treatment for malaria
World Health Organization Accessed 5 Feb 2016
Mass drug administration, mass screening and treatment and focal screening and treatment for malaria. WHO Evidence Review Group meeting report, April 2015. Background document for session 1. World Health Organization. 2015. http://www.who.int/malaria/mpac/mpac-sept2015-erg-mda-report.pdf. Accessed 5 Feb 2016.
Report from the expert review group on mass drug administration, GRADE tables. Background document for session 1. World Health Organization. 2015. http://www.who.int/malaria/mpac/mpac-sept2015-erg-mda-grade-tables.pdf. Accessed 5 Feb 2016.
Consensus modelling evidence to support the design of mass drug administration programmes. Background document for session 1. World Health Organization. 2015. http://www.who.int/malaria/mpac/mpac-sept2015-consensus-modelling-mda.pdf. Accessed 5 Feb 2016.
Review of delivery cost data on mass drug administration for malaria. Background document for session 1. World Health Organization. 2015. http://www.who.int/malaria/mpac/mpac-sept2015-cost-data-mda.pdf. Accessed 5 Feb 2016.
Recommendations on the role of mass drug administration, mass screening and treatment, and focal screening and treatment for malaria. World Health Organization. 2015. http://www.who.int/malaria/publications/atoz/role-of-mda-for-malaria/en/index.html. Accessed 5 Feb 2016.
Malaria in pregnancy. WHO Evidence Review Group meeting report, July 2015. Background document for session 4. World Health Organization. 2015. http://www.who.int/malaria/mpac/mpac-sept2015-erg-mip-report.pdf. Accessed 5 Feb 2016.
Updated WHO policy recommendation: intermittent preventive treatment of malaria in pregnancy using sulfadoxine-pyrimethamine (IPTp-SP). World Health Organization. 2012. http://www.who.int/malaria/publications/atoz/who-iptp-sp-policy-recommendation/en/. Accessed 5 Feb 2016.
Recommendations on intermittent screening and treatment in pregnancy and safety of artemisinin-based combination therapies in the first trimester. World Health Organization. 2015. http://www.who.int/malaria/publications/atoz/istp-and-act-in-pregnancy/en/index.html. Accessed 5 Feb 2016.
When can malaria control and elimination programs safely reduce vector control efforts? a simulation study. Background document for session 3. World Health Organization. 2015. http://www.who.int/malaria/mpac/scaleback-vector-control-simulation-study.pdf. Accessed 5 Feb 2016.
When is it safe for malaria control and elimination programs to scale back vector control?, presented on 17 Sep 2015. World Health Organization. 2015. http://www.who.int/malaria/mpac/mpac-sept2015-scaling-back-vc-presentation.pdf. Accessed 5 Feb 2016.
Information note on the risks associated with scale-back of vector control in areas where transmission has been reduced. World Health Organization. 2015. http://www.who.int/malaria/publications/atoz/scale-back-vector-control/en/index.html. Accessed 5 Feb 2016.
Implementation of G6PD testing and radical cure in P. vivax endemic countries: considerations, presented on 16 Sep 2015. World Health Organization. 2015. http://www.who.int/malaria/mpac/mpac-sept2015-g6pd-radical-cure-presentation.pdf. Accessed 5 Feb 2016.
Strategy for malaria elimination in the Greater Mekong Subregion (2015-2030). http://iris.wpro.who.int/bitstream/10665.1/10945/1/9789290617181-eng.pdf. Accessed 5 Feb 2016.
Updates of the Greater Mekong subregion elimination strategy, presented on 17 Sep 2015. World Health Organization. 2015. http://www.who.int/malaria/mpac/mpac-sept2015-gms-elimination-strategy-presentation.pdf. Accessed 5 Feb 2016.
Update on artemisinin and ACT resistance - September 2015. World Health Organization. 2015. http://www.who.int/malaria/publications/atoz/update-artemisinin-resistance-sep2015/en/. Accessed 5 Feb 2016.
Emergency response to artemisinin resistance in the Greater Mekong Subregion homepage. World Health Organization. 2015. http://www.who.int/malaria/areas/greater-mekong/en/
Report of the WHO Drafting Committee on Malaria Terminology, presented on 17 Sep 2015. World Health Organization. 2015. http://www.who.int/malaria/mpac/mpac-sept2015-malaria-terminology.pdf. Accessed 5 Feb 2016.
WHO update of malaria terminology. Background document for session 5. World Health Organization. 2015. http://www.who.int/malaria/mpac/mpac-sept2015-update-terminology.pdf. Accessed 5 Feb 2016.
Annex 2 World Health Organization Accessed 5 Feb 2016
Annex 2. Glossary. Background document for session 5. World Health Organization. 2015. http://www.who.int/malaria/mpac/mpac-sept2015-terminology-annex2.pdf. Accessed 5 Feb 2016.
Annex 1 World Health Organization Accessed 5 Feb 2016
Annex 1. Defining the term "malaria case". Background document for session 5. World Health Organization. 2015. http://www.who.int/malaria/mpac/mpac-sept2015-terminology-annex1.pdf. Accessed 5 Feb 2016.
Update on malaria elimination in the WHO European region. World Health Organization. 2015. http://www.who.int/malaria/mpac/mpac-sept2015-euro-elimination-presentation.pdf. Accessed 5 Feb 2016.
Update on the expert review group for the malaria elimination field manual and the malaria elimination certification panel I. World Health Organization. 2015. http://www.who.int/malaria/mpac/mpac-sept2015-erg-elimination-presentation.pdf. Accessed 5 Feb 2016.
Malaria elimination. A field manual for low and moderate endemic countries. World Health Organization. 2007. http://www.who.int/malaria/publications/atoz/9789241596084/en/. Accessed 5 Feb 2016.
Innovation to impact - WHO change plan for strengthening innovation, quality and use of vector-control tools. Background document for session. World Health Organization. 2015. http://www.who.int/malaria/mpac/mpac-sept2015-vector-control-innovation.pdf. Accessed 5 Feb 2016.
Innovation to impact - WHO change plan on evaluation of pesticides, presented on 17 September 2015. World Health Organization. 2015. http://www.who.int/malaria/mpac/mpac-sept2015-innovation-impact-presentation.pdf. Accessed 5 Feb 2016.
Malaria Policy Advisory Committee (MPAC) September 2015 meeting list of participants. World Health Organization. 2015. http://www.who.int/malaria/mpac/mpac-sept2015-list-of-participants.pdf. Accessed 5 Feb 2016.
